Journal article
Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity
Biochemical and Biophysical Research Communications, Vol.386(1), pp.16-20
08/14/2009
DOI: 10.1016/j.bbrc.2009.05.106
PMCID: PMC2976596
PMID: 19486896
Abstract
AMP-activated protein kinase (AMPK) is an energy sensing metabolic switch in mammalian cells. Here, we report our novel finding that AMPK is lost in all immune cells of experimental autoimmune encephalomyelitis (EAE), an inflammatory disease of Central Nervous System (CNS). AMPKα1 is predominantly expressed in T cells and antigen presenting cells (APCs), which are primarily involved in EAE disease progression. AMPK is lost at protein level in spleen macrophages, total T cells and their subsets (CD4, CD8 and regulatory T cells) isolated from EAE afflicted animals compared to control, without affecting its mRNA levels suggesting that the loss of AMPK protein is the result of posttranscriptional modification. To examine its pathological relevance in inflammatory disease, EAE was induced in wild type (+/+) and AMPKα1 null mice (−/−) using MOG35–55 peptide. AMPKα1−/− mice exhibited severe EAE disease with profound infiltration of mononuclear cells compared to wild type mice however, AMPKα2 is not involved in enhancing the severity of the disease. Spleen cells isolated from AMPKα1−/− immunized mice exhibited a significant induction in the production of IFNγ. Our study identifies AMPK as a down regulated target during disease in all immune cells and possibly restoring AMPK may serve as a novel therapeutic target in autoimmune diseases like multiple sclerosis (MS).
Details
- Title: Subtitle
- Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity
- Creators
- Narender Nath - Department of Pediatrics, Medical University of South Carolina, SC 29425, USAMusfiquidin Khan - Department of Pediatrics, Medical University of South Carolina, SC 29425, USARamandeep Rattan - Department of Experimental Pathology, Mayo Clinic, Rochester, MN 55902, USAAshutosh Mangalam - Department of Immunology, Mayo Clinic, Rochester, MN 55902, USARandhir S Makkar - Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USACarloe de Meester - Université catholique de Louvain, Division of Cardiology, School of Medicine, Brussels, BelgiumLuc Bertrand - Université catholique de Louvain, Division of Cardiology, School of Medicine, Brussels, BelgiumInderjit Singh - Department of Pediatrics, Medical University of South Carolina, SC 29425, USAYingjie Chen - Division of Cardiovascular and Center for Vascular Biology, University of Minnesota, Minneapolis, MN 55455, USABenoit Viollet - Institut Cochin, Université René Descartes, Centre National de la Recherche Scientifique (UMR 8104), Paris, FranceShailendra Giri - Department of Pediatrics, Medical University of South Carolina, SC 29425, USA
- Resource Type
- Journal article
- Publication Details
- Biochemical and Biophysical Research Communications, Vol.386(1), pp.16-20
- DOI
- 10.1016/j.bbrc.2009.05.106
- PMID
- 19486896
- PMCID
- PMC2976596
- NLM abbreviation
- Biochem Biophys Res Commun
- ISSN
- 0006-291X
- eISSN
- 1090-2104
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 08/14/2009
- Academic Unit
- Pathology; Iowa Neuroscience Institute
- Record Identifier
- 9983905643902771
Metrics
23 Record Views